aztreonam has been researched along with Enteric Fever in 10 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with clinical typhoid fever plus a blood, bone marrow, or bile positive for Salmonella typhi or Salmonella paratyphi were included in an open clinical trial to compare the efficacy of aztreonam (6 g/day [2 g intravenously every 8 h]) given for 10 days with that of chloramphenicol (50 mg/kg of body weight per day [intravenously or orally]) administered for 14 days." | 9.07 | Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever. ( Carrillo, C; DuPont, HL; Echevarría, J; Gotuzzo, E; Grados, P; Maguiña, C; Sánchez, J, 1994) |
| "We compared aztreonam with chloramphenicol in a randomized trial involving the treatment of 36 children with typhoid fever." | 9.06 | Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever. ( Ortega, L; Santos, JI; Tanaka-Kido, J, 1990) |
| "10 patients with meningitis due to unusual gram-negative organisms (Pseudomonas, Proteus, Salmonella and Klebsiella) were effectively treated with aztreonam." | 7.68 | Aztreonam for treating meningitis caused by gram-negative rods. ( Bishay, E; Farid, Z; Girgis, N; Kilpatrick, M, 1991) |
| "Aztreonam treatment was successful in 4 cases of typhoid fever." | 7.68 | Successful aztreonam treatment of acute typhoid fever after chloramphenicol failure. ( Bishay, E; Farid, Z; Girgis, NI; Kamal, M; Kilpatrick, ME, 1990) |
| "Aztreonam was given intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days to thirty patients." | 6.67 | Aztreonam compared to chloramphenicol in the treatment of enteric fevers. ( Farid, Z; Girgis, NI; Kilpatrick, ME; Podgore, JK; Sultan, Y, 1992) |
| "Patients with clinical typhoid fever plus a blood, bone marrow, or bile positive for Salmonella typhi or Salmonella paratyphi were included in an open clinical trial to compare the efficacy of aztreonam (6 g/day [2 g intravenously every 8 h]) given for 10 days with that of chloramphenicol (50 mg/kg of body weight per day [intravenously or orally]) administered for 14 days." | 5.07 | Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever. ( Carrillo, C; DuPont, HL; Echevarría, J; Gotuzzo, E; Grados, P; Maguiña, C; Sánchez, J, 1994) |
| "We compared aztreonam with chloramphenicol in a randomized trial involving the treatment of 36 children with typhoid fever." | 5.06 | Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever. ( Ortega, L; Santos, JI; Tanaka-Kido, J, 1990) |
| "10 patients with meningitis due to unusual gram-negative organisms (Pseudomonas, Proteus, Salmonella and Klebsiella) were effectively treated with aztreonam." | 3.68 | Aztreonam for treating meningitis caused by gram-negative rods. ( Bishay, E; Farid, Z; Girgis, N; Kilpatrick, M, 1991) |
| "Aztreonam treatment was successful in 4 cases of typhoid fever." | 3.68 | Successful aztreonam treatment of acute typhoid fever after chloramphenicol failure. ( Bishay, E; Farid, Z; Girgis, NI; Kamal, M; Kilpatrick, ME, 1990) |
| "Cefixime (7." | 2.68 | Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. ( Farid, Z; Girgis, NI; Hammad, O; Sultan, Y, 1995) |
| "Aztreonam was given intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days to thirty patients." | 2.67 | Aztreonam compared to chloramphenicol in the treatment of enteric fevers. ( Farid, Z; Girgis, NI; Kilpatrick, ME; Podgore, JK; Sultan, Y, 1992) |
| "typhi were effective against typhoid caused by ampicillin, chloramphenicol and sulfamethoxazole/trimethoprim-resistant strains." | 1.28 | Therapy of multidrug resistant typhoid in 58 children. ( Bhutta, ZA; Farooqui, BJ; Naqvi, SH, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoon, HJ | 1 |
| Cho, SH | 1 |
| Kim, SH | 1 |
| Girgis, NI | 4 |
| Sultan, Y | 2 |
| Hammad, O | 1 |
| Farid, Z | 5 |
| Gotuzzo, E | 1 |
| Echevarría, J | 1 |
| Carrillo, C | 1 |
| Sánchez, J | 1 |
| Grados, P | 1 |
| Maguiña, C | 1 |
| DuPont, HL | 1 |
| Kilpatrick, ME | 2 |
| Podgore, JK | 1 |
| Naqvi, SH | 1 |
| Bhutta, ZA | 1 |
| Farooqui, BJ | 1 |
| Choo, KE | 1 |
| Ariffin, WA | 1 |
| Ong, KH | 1 |
| Sivakumaran, S | 1 |
| Kilpatrick, M | 1 |
| Girgis, N | 1 |
| Bishay, E | 2 |
| Kamal, M | 1 |
| Tanaka-Kido, J | 1 |
| Ortega, L | 1 |
| Santos, JI | 1 |
| Abu el Ella, AH | 1 |
| el-Messidi, M | 1 |
| Dessouki, A | 1 |
| Woody, J | 1 |
5 trials available for aztreonam and Enteric Fever
| Article | Year |
|---|---|
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalo | 1995 |
Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever.
Topics: Adolescent; Adult; Aztreonam; Chloramphenicol; Double-Blind Method; Feces; Female; Humans; Male; Par | 1994 |
Aztreonam compared to chloramphenicol in the treatment of enteric fevers.
Topics: Administration, Oral; Adolescent; Adult; Aztreonam; Child; Chloramphenicol; Female; Humans; Injectio | 1992 |
Aztreonam failure in typhoid fever.
Topics: Aztreonam; Child; Chloramphenicol; Drug Evaluation; Drug Resistance, Microbial; Humans; Prospective | 1991 |
Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever.
Topics: Adolescent; Alkaline Phosphatase; Aztreonam; Child; Child, Preschool; Chloramphenicol; Clinical Tria | 1990 |
5 other studies available for aztreonam and Enteric Fever
| Article | Year |
|---|---|
A case of multidrug-resistant Salmonella enterica serovar Typhi treated with a bench to bedside approach.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteremia; Drug Resistance, Bacterial; Drug Resistance, Mu | 2009 |
Therapy of multidrug resistant typhoid in 58 children.
Topics: Adolescent; Ampicillin Resistance; Aztreonam; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chlo | 1992 |
Aztreonam for treating meningitis caused by gram-negative rods.
Topics: Adult; Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Hum | 1991 |
Successful aztreonam treatment of acute typhoid fever after chloramphenicol failure.
Topics: Adult; Aztreonam; Chloramphenicol; Female; Humans; Male; Salmonella typhi; Typhoid Fever | 1990 |
Aztreonam in the treatment of enteric fevers.
Topics: Adolescent; Adult; Aztreonam; Child; Female; Humans; Male; Paratyphoid Fever; Salmonella paratyphi A | 1987 |